Full-Time

Director or Senior Director

Toxicology

Posted on 9/20/2024

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops therapies using targeted protein degradation

Biotechnology
Healthcare

Senior

Belmont, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Toxicology or Pharmacology, DVM, or related field
  • A minimum of 5 years’ experience in the life science industry in a Toxicology or Pathology role
  • Proven track record of conducting preclinical drug safety assessment studies
  • Ability to make sound risk assessments and represent toxicology perspectives on project teams and with external partners
  • Direct experience developing the toxicology strategy and data package supporting the clinical development of small molecule therapeutics
  • Demonstrated track record of toxicology leadership on multiple programs at early and late stages of development
  • Experience with EMA and FDA CTA/IND submissions and regulatory interactions
  • Experience partnering with internal stakeholders and colleagues to ensure comprehensive preclinical safety approaches are developed as part of the program strategy
  • Experience working with outsourced studies
  • Ability to perform in fast-paced and dynamic environment
  • Excellent communication and organizational skills and attention to detail
Responsibilities
  • Provide expert support, guidance, and strategy on project safety assessments, with a specific focus on discovery & IND-stage small molecule projects.
  • Providing scientific and regulatory toxicology expertise to cross-functional project teams
  • Develop toxicology strategies and plans for programs in all stages of drug development
  • Oversee toxicology and safety pharmacology studies at multiple Contract Research Organizations
  • Design and execute GLP, non-GLP, and investigative toxicology studies
  • Monitor toxicology studies for appropriate conduct, accuracy, and timely execution; review draft reports and ensure quality submission-ready documents for regulatory authorities
  • Proactively respond to study issues and resolve problems with study director
  • Prepare verbal and written summaries for internal discussions
  • Work with the Preclinical Development team to develop optimal strategies to address specific safety issues and partner with project teams
  • Lead authorship of toxicology and/or safety pharmacology sections of various regulatory documents (e.g., pre-IND briefing documents, IND/CTA, IBs etc.)
  • Represent company at meetings with regulatory agencies
  • Present summary data to project teams and Kymera senior leadership

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on protein degradation, which can lead to more effective therapies for unmet medical needs. The company's goal is to advance next-generation medicines through strategic partnerships, such as their collaboration with Sanofi, and to generate revenue through research partnerships and future drug sales.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera raised $225M and $275M in public offerings, boosting financial resources.
  • Partnership with Neosphere advances molecular glue target discovery, enhancing research capabilities.
  • HSBC's investment reflects confidence in Kymera's targeted protein degradation technology.

What critics are saying

  • Reliance on partnerships like Sanofi may affect autonomy in drug development.
  • Public offering funds may not suffice for long-term R&D and operational needs.
  • Market competition in protein degradation could impact Kymera's market share.

What makes Kymera Therapeutics unique

  • Kymera's Pegasus Platform enables precise targeting of disease-causing proteins.
  • The company focuses on targeted protein degradation for innovative drug development.
  • Kymera collaborates with Sanofi to advance novel protein degrader therapies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE